325 results
Page 4 of 17
8-K
EX-99.1
u4zj4s5u
27 Oct 14
Other Events
12:00am
8-K
76iiqm vm5hcv1d
27 Oct 14
Other Events
12:00am
8-K
mjf9g2sc
21 Oct 14
Regulation FD Disclosure
12:00am
8-K
EX-99
6buboupxtq88krcq
17 Oct 14
Other Events
12:00am
8-K
t9g0b tlx55
17 Oct 14
Other Events
12:00am
8-K
EX-99.1
ri7fz f0apk
8 Sep 14
Other Events
12:00am
8-K
EX-99.5
4q4l1e zsc7uu873uv
8 Sep 14
Other Events
12:00am
8-K
EX-99.4
ud0yvsmx
8 Sep 14
Other Events
12:00am
8-K
EX-99.2
0p46tv79
8 Sep 14
Other Events
12:00am
8-K
EX-99.1
v1she93o
9 Jul 14
Anoro® Ellipta® (umeclidinium/vilanterol) approved in Australia for Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-99
h6aijxs9dli5ygzyx
7 Jul 14
Other Events
12:00am
8-K
EX-99.1
uih 8f7ryugjj40jo
21 May 14
Regulation FD Disclosure
12:00am
8-K
EX-99
gg63kl52s2o
28 Apr 14
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
jnwbav b5
22 Apr 14
Breo™Ellipta® (fluticasone furoate/vilanterol trifenatate) approved in Australia for Asthma and Chronic Obstructive Pulmonary Disease
12:00am
8-K
EX-10.8
25vlf
21 Apr 14
Theravance Closes Private Placement of $450 Million of 9% Non-Recourse Notes Supporting Strategic Separation Process
12:00am
8-K
EX-99.1
zhdje63
9 Apr 14
Regulation FD Disclosure
12:00am